Plain-English translation of NCT04745390 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares two ways of delivering radiation therapy to treat cancer in the liver. One group receives a standard radiation dose that all patients get, while the other group receives a personalized dose calculated specifically for them based on their tumor's characteristics. The goal is to see if the personalized approach helps patients live longer and have fewer side effects.
Most patients with liver cancer cannot have surgery, leaving them with very limited treatment options and poor survival rates. This trial exists to test whether a smarter, personalized way of giving radiation therapy could improve outcomes for patients who cannot be treated with surgery.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive radiation therapy to your liver tumor delivered over 5 sessions, with treatments every other day. Depending on which group you're randomly assigned to, you'll receive either a standard radiation dose that all patients get, or a personalized dose calculated for your specific tumor. The radiation itself takes about 15–30 minutes per session, and you'll likely complete all treatments within 1–2 weeks.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Canada